2022
DOI: 10.3389/fneur.2022.901467
|View full text |Cite
|
Sign up to set email alerts
|

Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial

Abstract: and Polymeropoulos MH ( ) Once-daily tasimelteon (VEC-) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 12 publications
0
0
0
Order By: Relevance